Kolstad, A., Laurell, A., Jerkeman, M., Grønbæk, K., Elonen, E., Räty, R., . . . Geisler, C. H. (2014). Nordic MCL3 study: (90)Y-ibritumomab-tiuxetan added to BEAM/C in non-CR patients before transplant in mantle cell lymphoma. American Society of Hematology.
Citação norma ChicagoKolstad, Arne, et al. Nordic MCL3 Study: (90)Y-ibritumomab-tiuxetan Added to BEAM/C in Non-CR Patients Before Transplant in Mantle Cell Lymphoma. American Society of Hematology, 2014.
Citação norma MLAKolstad, Arne, et al. Nordic MCL3 Study: (90)Y-ibritumomab-tiuxetan Added to BEAM/C in Non-CR Patients Before Transplant in Mantle Cell Lymphoma. American Society of Hematology, 2014.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.